Safety and efficacy results from Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) In relapsed/refractory (R/R) large B-cell lymphoma (LBCL) Meeting Abstract
| Authors: | Abramson, J.; Palomba, M. L.; Gordon, L.; Lunning, M.; Wang, M.; Arnason, J.; Mehta, A.; Purev, E.; Maloney, D.; Andreadis, C.; Sehgal, A.; Solomon, S.; Ghosh, N.; Albertson, T.; Garcia, J.; Kostic, A.; Li, D.; Kim, Y.; Siddiqi, T. |
| Abstract Title: | Safety and efficacy results from Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) In relapsed/refractory (R/R) large B-cell lymphoma (LBCL) |
| Meeting Title: | 34. Deutscher Krebskongress (DKK) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Feb 19-22 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-02-01 |
| Start Page: | 215 |
| Language: | English |
| ACCESSION: | WOS:000517158700539 |
| PROVIDER: | wos |
| DOI: | 10.1159/000506491 |
| Notes: | "34th German Cancer Congress" -- Meeting Abstract: 976 -- Source: Wos |
